Bär & Karrer acted as legal advisor to SGS SA in this matter. At its AGM held on 26 March 2024, SGS SA proposed to shareholders,...
SGS SA’s Scrip Dividend Transaction
Novartis’ Spin-off of Sandoz’s Generic and Biosimilar Drugs Business
Bär & Karrer acted as Swiss legal and tax advisor to Novartis and Sandoz. Cravath represented Novartis as U.S. tax counsel. Novartis has completed the spin-off...
MCH Group’s CHF 76.9 Million Rights Offering
Homburger advised MCH Group in this transaction. Bär & Karrer advised Lupa in connection with the transaction. MCH Group AG, a leading international live marketing company,...
DSM’s Merger With Firmenich
Clifford Chance has advised J.P. Morgan on the bridge financing facility of EUR 3.0 billion in connection with the merger of DSM-Firmenich. Homburger AG advised Sentarom...
CSL’s A$16.4 Billion Acquisition of Vifor Pharma
Homburger AG, Bär & Karrer, Simpson Thacher & Bartlett LLP, and Allens acted as joint legal advisors to CSL. PJT Partners, BofA Securities and Goldman Sachs...
Roche Holding’s CHF19 Billion Bridge Financing Agreement
Baker McKenzie advised BNP Paribas and Deutsche Bank on the deal. Lenz & Staehelin acted as legal advisor to the Roche family pool. Bär & Karrer...
Bain Capital And Cinven’s CHF 4.2 Billion Acquisition of Lonza’s Specialty Ingredients Business
Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin, Freshfields Bruckhaus Deringer, Kirkland & Ellis and Elvinger Hoss Prussen...